JOSHUA M STOLKER
- Type
- Physician · Allopathic & Osteopathic Physicians / Internal Medicine / Interventional Cardiology
- Where
- WASHINGTON, MO
- NPI
- 1447292875
- Received
- $1,197,761 in 1,387 records, 2019 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 115 | $124,414 |
| 2024 | General payment | 143 | $106,025 |
| 2023 | General payment | 226 | $162,738 |
| 2022 | General payment | 181 | $182,399 |
| 2021 | General payment | 195 | $190,104 |
| 2020 | General payment | 227 | $213,028 |
| 2019 | General payment | 300 | $219,051 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 400 | $940,208 |
| Consulting Fee | 47 | $176,949 |
| Travel and Lodging | 237 | $52,771 |
| Food and Beverage | 689 | $27,500 |
| Education | 14 | $332 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-16 | E.R. Squibb & Sons, L.L.C. | $18 | Food and Beverage | Cash or cash equivalent | CAMZYOS Drug, Cardiovascular | 2025 | |
| 2025-12-02 | Boehringer Ingelheim Pharmaceuticals, Inc. | $12 | Food and Beverage (2 payments) | In-kind items and services | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-12-01 | Esperion Therapeutics, Inc. | $19 | Food and Beverage | In-kind items and services | NEXLETOL Drug, ANTILIPEMIC AGENTS | 2025 | |
| 2025-11-10 | HEARTFLOW, INC. | $23 | Food and Beverage | Cash or cash equivalent | FFRct Device, Coronary | 2025 | |
| 2025-11-06 | Novo Nordisk Inc | $32 | Education | In-kind items and services | Drug, Multiple Therapeutic Areas | 2025 | |
| 2025-11-05 | Boehringer Ingelheim Pharmaceuticals, Inc. | $81 | Travel and Lodging | In-kind items and services | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-11-05 | Boehringer Ingelheim Pharmaceuticals, Inc. | $20 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-11-04 | Boehringer Ingelheim Pharmaceuticals, Inc. | $22 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-10-29 | Boehringer Ingelheim Pharmaceuticals, Inc. | $5,700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-10-29 | Boehringer Ingelheim Pharmaceuticals, Inc. | $2,850 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-10-29 | Boehringer Ingelheim Pharmaceuticals, Inc. | $2,850 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-10-29 | Novo Nordisk Inc | $2,355 | Consulting Fee | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-10-28 | Novo Nordisk Inc | $2,355 | Consulting Fee | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-10-18 | Philips North America LLC | $147 | Food and Beverage | Cash or cash equivalent | IGT Devices Undivided Device, Medical Device | 2025 | |
| 2025-10-14 | Boehringer Ingelheim Pharmaceuticals, Inc. | $520 | Travel and Lodging | In-kind items and services | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-10-14 | Boehringer Ingelheim Pharmaceuticals, Inc. | $118 | Travel and Lodging | In-kind items and services | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-10-14 | Boehringer Ingelheim Pharmaceuticals, Inc. | $32 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-10-14 | Boehringer Ingelheim Pharmaceuticals, Inc. | $15 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-10-07 | Novo Nordisk Inc | $834 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-09-25 | Amgen Inc. | $138 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-09-25 | Penumbra, Inc. | $36 | Travel and Lodging | Cash or cash equivalent | Indigo System Device, Peripheral Intervention | 2025 | |
| 2025-09-24 | ABIOMED | $31 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-09-17 | AstraZeneca Pharmaceuticals LP | $21 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2025 | |
| 2025-09-12 | Penumbra, Inc. | $211 | Travel and Lodging | Cash or cash equivalent | Indigo System Device, Peripheral Intervention | 2025 | |
| 2025-09-12 | Penumbra, Inc. | $39 | Food and Beverage | Cash or cash equivalent | Penumbra System Device, Neurointervention | 2025 | |
| 2025-09-12 | Edwards Lifesciences Corporation | $25 | Food and Beverage | In-kind items and services | SAPIEN 3 Ultra RESILIA Device, Transcatheter Heart Valves | 2025 | |
| 2025-09-11 | Penumbra, Inc. | $413 | Travel and Lodging | Cash or cash equivalent | Indigo System Device, Peripheral Intervention | 2025 | |
| 2025-09-11 | Penumbra, Inc. | $363 | Travel and Lodging | Cash or cash equivalent | Indigo System Device, Peripheral Intervention | 2025 | |
| 2025-09-11 | Penumbra, Inc. | $293 | Food and Beverage | Cash or cash equivalent | Indigo System Device, Peripheral Intervention | 2025 | |
| 2025-09-11 | Penumbra, Inc. | $140 | Food and Beverage | Cash or cash equivalent | Indigo System Device, Peripheral Intervention | 2025 | |
| 2025-09-11 | Penumbra, Inc. | $55 | Travel and Lodging | Cash or cash equivalent | Indigo System Device, Peripheral Intervention | 2025 | |
| 2025-09-11 | Penumbra, Inc. | $39 | Travel and Lodging | Cash or cash equivalent | Indigo System Device, Peripheral Intervention | 2025 | |
| 2025-09-10 | Boehringer Ingelheim Pharmaceuticals, Inc. | $5,700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-09-10 | Boehringer Ingelheim Pharmaceuticals, Inc. | $2,850 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-09-10 | Boehringer Ingelheim Pharmaceuticals, Inc. | $2,850 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-09-10 | Boehringer Ingelheim Pharmaceuticals, Inc. | $191 | Travel and Lodging | In-kind items and services | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-09-10 | Boehringer Ingelheim Pharmaceuticals, Inc. | $34 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-09-10 | Boehringer Ingelheim Pharmaceuticals, Inc. | $19 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-09-10 | Amgen Inc. | $8 | Food and Beverage | In-kind items and services | REPATHA Biological, Cardiovascular | 2025 | |
| 2025-09-05 | Amgen Inc. | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPATHA Biological, Cardiovascular | 2025 | |
| 2025-09-04 | Boehringer Ingelheim Pharmaceuticals, Inc. | $4,950 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-08-27 | Boehringer Ingelheim Pharmaceuticals, Inc. | $1,520 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-08-26 | Boehringer Ingelheim Pharmaceuticals, Inc. | $425 | Travel and Lodging | In-kind items and services | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-08-26 | Boehringer Ingelheim Pharmaceuticals, Inc. | $333 | Travel and Lodging | In-kind items and services | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-08-26 | Boehringer Ingelheim Pharmaceuticals, Inc. | $124 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-08-25 | Boehringer Ingelheim Pharmaceuticals, Inc. | $168 | Travel and Lodging | In-kind items and services | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-08-21 | Novo Nordisk Inc | $31 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-08-14 | Boehringer Ingelheim Pharmaceuticals, Inc. | $124 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-08-07 | Amgen Inc. | $14 | Food and Beverage | In-kind items and services | REPATHA Biological, Cardiovascular | 2025 | |
| 2025-08-05 | ABIOMED | $19 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-07-21 | Amgen Inc. | $7 | Food and Beverage | In-kind items and services | REPATHA Biological, Cardiovascular | 2025 | |
| 2025-07-17 | ABIOMED | $112 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-07-09 | Boehringer Ingelheim Pharmaceuticals, Inc. | $1,520 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-07-09 | Boehringer Ingelheim Pharmaceuticals, Inc. | $13 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-06-18 | Boston Scientific Corporation | $15 | Food and Beverage | In-kind items and services | WATCHMAN FLX Device, WATCHMAN FLX_IC | 2025 | |
| 2025-06-06 | Novo Nordisk Inc | $23 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-06-05 | Novo Nordisk Inc | $4,513 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-06-05 | Novo Nordisk Inc | $1,962 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-06-05 | Novo Nordisk Inc | $124 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-06-05 | Novo Nordisk Inc | $59 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-06-02 | Boehringer Ingelheim Pharmaceuticals, Inc. | $9 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-05-29 | Amgen Inc. | $12 | Food and Beverage | In-kind items and services | REPATHA Biological, Cardiovascular | 2025 | |
| 2025-05-20 | Amgen Inc. | $11 | Food and Beverage | In-kind items and services | REPATHA Biological, Cardiovascular | 2025 | |
| 2025-05-19 | W. L. Gore & Associates, Inc. | $300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Product in Development Device, Devices | 2025 | |
| 2025-05-19 | AstraZeneca Pharmaceuticals LP | $14 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-05-15 | Abbott Laboratories | $20 | Food and Beverage | In-kind items and services | DIAMONDBACK CORONARY Device, Vascular | 2025 | |
| 2025-05-08 | Novo Nordisk Inc | $8,046 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-05-08 | Novo Nordisk Inc | $4,710 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-05-08 | Novo Nordisk Inc | $163 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-05-08 | Novo Nordisk Inc | $116 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-05-07 | Lilly USA, LLC | $1,520 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2025 | |
| 2025-05-06 | Teleflex LLC | $180 | Food and Beverage | In-kind items and services | GUIDELINER Device, INTERVENTIONAL ACCESS | 2025 | |
| 2025-05-05 | Lilly USA, LLC | $1,520 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2025 | |
| 2025-05-01 | Novo Nordisk Inc | $5,102 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-05-01 | Novo Nordisk Inc | $123 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-04-30 | Novo Nordisk Inc | $8,438 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-04-30 | Novo Nordisk Inc | $565 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-04-30 | Novo Nordisk Inc | $181 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-04-30 | Novo Nordisk Inc | $179 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-04-30 | Novo Nordisk Inc | $163 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-04-29 | Teleflex LLC | $108 | Travel and Lodging | In-kind items and services | GUIDELINER Device, INTERVENTIONAL ACCESS | 2025 | |
| 2025-04-29 | Teleflex LLC | $45 | Travel and Lodging | In-kind items and services | GUIDELINER Device, INTERVENTIONAL ACCESS | 2025 | |
| 2025-04-28 | Teleflex LLC | $303 | Travel and Lodging | In-kind items and services | GUIDELINER Device, INTERVENTIONAL ACCESS | 2025 | |
| 2025-04-27 | Teleflex LLC | $33 | Food and Beverage | In-kind items and services | GUIDELINER Device, INTERVENTIONAL ACCESS | 2025 | |
| 2025-04-23 | Teleflex LLC | $66 | Food and Beverage | In-kind items and services | GUIDELINER Device, INTERVENTIONAL ACCESS | 2025 | |
| 2025-04-17 | ABIOMED | $150 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-04-15 | AstraZeneca Pharmaceuticals LP | $23 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2025 | |
| 2025-04-10 | Novo Nordisk Inc | $8,438 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-04-10 | Novo Nordisk Inc | $6,868 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-04-10 | Novo Nordisk Inc | $218 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-04-10 | Novo Nordisk Inc | $193 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-04-10 | Novo Nordisk Inc | $193 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-04-10 | Novo Nordisk Inc | $178 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-04-10 | Novo Nordisk Inc | $139 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-04-10 | Novo Nordisk Inc | $133 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-04-09 | Boston Scientific Corporation | $147 | Food and Beverage | In-kind items and services | AVVIGO Guidance System Device, AVVIGO_IC | 2025 | |
| 2025-04-08 | ABIOMED | $99 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-04-03 | Teleflex LLC | $23 | Food and Beverage | In-kind items and services | SUPERCROSS Device, INTERVENTIONAL ACCESS | 2025 | |
| 2025-03-18 | Novo Nordisk Inc | $8,046 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-03-18 | Novo Nordisk Inc | $387 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-03-18 | Novo Nordisk Inc | $124 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-03-18 | Novo Nordisk Inc | $118 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-03-13 | Amgen Inc. | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPATHA Biological, Cardiovascular | 2025 | |
| 2025-03-08 | Novo Nordisk Inc | $10,362 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-03-08 | Novo Nordisk Inc | $584 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-03-08 | Novo Nordisk Inc | $399 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-03-08 | Novo Nordisk Inc | $323 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-03-08 | Novo Nordisk Inc | $168 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-02-24 | Lilly USA, LLC | $2,280 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2025 | |
| 2025-02-21 | ABIOMED | $140 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-02-14 | Lilly USA, LLC | $1,520 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2025 | |
| 2025-02-12 | Teleflex LLC | $631 | Travel and Lodging | In-kind items and services | GUIDELINER Device, INTERVENTIONAL ACCESS | 2025 | |
| 2025-02-06 | Lilly USA, LLC | $1,520 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2025 | |
| 2025-02-05 | Edwards Lifesciences Corporation | $23 | Food and Beverage | In-kind items and services | SAPIEN 3 Ultra RESILIA Device, Transcatheter Heart Valves | 2025 | |
| 2025-01-08 | ABIOMED | $99 | Food and Beverage | In-kind items and services | 2025 | ||
| 2024-12-06 | Novo Nordisk Inc | $18 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2024 | |
| 2024-12-03 | Amgen Inc. | $2,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Repatha Biological, Cardiology | 2024 | |
| 2024-12-03 | Amgen Inc. | $13 | Food and Beverage | In-kind items and services | Repatha Biological, Cardiology | 2024 | |
| 2024-11-25 | Shockwave Medical, Inc | $150 | Food and Beverage | In-kind items and services | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter Device, Lithoplasty | 2024 | |
| 2024-11-21 | Amgen Inc. | $119 | Food and Beverage | In-kind items and services | Repatha Biological, Cardiology | 2024 | |
| 2024-11-18 | E.R. Squibb & Sons, L.L.C. | $29 | Food and Beverage | Cash or cash equivalent | CAMZYOS Drug, Cardiovascular | 2024 | |
| 2024-11-18 | Novo Nordisk Inc | $10 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2024 | |
| 2024-11-17 | Amgen Inc. | $114 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-11-16 | AGEPHA Pharma FZ LLC | $200 | Food and Beverage | In-kind items and services | LODOCO Drug, Cardiovascular Diseases | 2024 | |
| 2024-11-16 | AGEPHA Pharma FZ LLC | $6 | Food and Beverage | In-kind items and services | LODOCO Drug, Cardiovascular Diseases | 2024 | |
| 2024-11-13 | Boston Scientific Corporation | $140 | Food and Beverage | In-kind items and services | AVVIGO Guidance System Device, AVVIGO_IC | 2024 | |
| 2024-11-13 | Novo Nordisk Inc | $14 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2024 | |
| 2024-11-12 | Novo Nordisk Inc | $1,550 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2024 | |
| 2024-11-07 | Novo Nordisk Inc | $1,550 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2024 | ||
| 2024-11-07 | ABIOMED | $143 | Food and Beverage | Cash or cash equivalent | Impella Device, Cardiology/Vascular Diseases | 2024 | |
| 2024-11-05 | ABIOMED | $143 | Food and Beverage | Cash or cash equivalent | Impella Device, Cardiology/Vascular Diseases | 2024 | |
| 2024-10-31 | AstraZeneca Pharmaceuticals LP | $24 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-10-30 | Edwards Lifesciences Corporation | $115 | Food and Beverage | In-kind items and services | SAPIEN 3 Ultra RESILIA Device, Transcatheter Heart Valves | 2024 | |
| 2024-10-30 | ABIOMED | $34 | Food and Beverage | Cash or cash equivalent | Impella Device, Cardiology/Vascular Diseases | 2024 | |
| 2024-10-17 | Novo Nordisk Inc | $1,550 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2024 | |
| 2024-10-14 | Novo Nordisk Inc | $1,550 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2024 | |
| 2024-10-14 | Amgen Inc. | $75 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-10-10 | Novo Nordisk Inc | $1,550 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2024 | |
| 2024-10-01 | Novo Nordisk Inc | $1,550 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2024 | |
| 2024-09-26 | ABIOMED | $90 | Food and Beverage | Cash or cash equivalent | Impella Device, Cardiology/Vascular Diseases | 2024 | |
| 2024-09-25 | Novo Nordisk Inc | $1,938 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2024 | |
| 2024-09-24 | Novo Nordisk Inc | $1,550 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2024 | |
| 2024-09-23 | Novo Nordisk Inc | $1,550 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2024 | |
| 2024-09-19 | Novo Nordisk Inc | $1,550 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2024 | |
| 2024-09-06 | Novo Nordisk Inc | $1,938 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2024 | |
| 2024-08-29 | Lilly USA, LLC | $1,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2024 | |
| 2024-08-29 | Novo Nordisk Inc | $121 | Food and Beverage | In-kind items and services | Drug | 2024 | |
| 2024-08-28 | Novo Nordisk Inc | $1,550 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2024 | |
| 2024-08-24 | Boston Scientific Corporation | $20 | Food and Beverage | In-kind items and services | LUX-Dx Insertable Cardiac Monitor Device, LUX-Dx_CRM | 2024 | |
| 2024-08-09 | Novo Nordisk Inc | $1,550 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2024 | |
| 2024-08-08 | Novo Nordisk Inc | $1,550 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2024 | |
| 2024-08-06 | Novo Nordisk Inc | $1,938 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2024 | |
| 2024-07-31 | Amgen Inc. | $4 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-07-25 | Novo Nordisk Inc | $7,943 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2024 | ||
| 2024-07-25 | Novo Nordisk Inc | $6,393 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2024 | ||
| 2024-07-25 | Novo Nordisk Inc | $284 | Travel and Lodging | In-kind items and services | 2024 | ||
| 2024-07-25 | Novo Nordisk Inc | $281 | Travel and Lodging | In-kind items and services | 2024 | ||
| 2024-07-25 | Novo Nordisk Inc | $281 | Travel and Lodging | In-kind items and services | 2024 | ||
| 2024-07-25 | Novo Nordisk Inc | $171 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-07-25 | Novo Nordisk Inc | $125 | Travel and Lodging | In-kind items and services | 2024 | ||
| 2024-07-25 | Novo Nordisk Inc | $23 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-07-11 | Boehringer Ingelheim Pharmaceuticals, Inc. | $4,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-07-11 | Boehringer Ingelheim Pharmaceuticals, Inc. | $2,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-07-11 | Boehringer Ingelheim Pharmaceuticals, Inc. | $2,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-07-11 | Esperion Therapeutics, Inc. | $25 | Food and Beverage | In-kind items and services | NEXLETOL Drug, ANTILIPEMIC AGENTS | 2024 | |
| 2024-07-08 | Boehringer Ingelheim Pharmaceuticals, Inc. | $220 | Travel and Lodging | In-kind items and services | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-07-08 | Boehringer Ingelheim Pharmaceuticals, Inc. | $14 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-07-08 | Boehringer Ingelheim Pharmaceuticals, Inc. | $12 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-07-08 | Boehringer Ingelheim Pharmaceuticals, Inc. | $7 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-06-27 | ABIOMED | $154 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-06-26 | Novo Nordisk Inc | $1,550 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2024 | |
| 2024-06-25 | Novo Nordisk Inc | $1,938 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2024 | |
| 2024-06-14 | Lilly USA, LLC | $1,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2024 | |
| 2024-06-14 | Boston Scientific Corporation | $45 | Food and Beverage | In-kind items and services | WATCHMAN FLX Device, WATCHMAN FLX_IC | 2024 | |
| 2024-06-14 | Medtronic, Inc. | $36 | Food and Beverage | In-kind items and services | MICRA Device, Pacemakers | 2024 | |
| 2024-06-06 | Boehringer Ingelheim Pharmaceuticals, Inc. | $619 | Travel and Lodging | In-kind items and services | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-06-06 | Boehringer Ingelheim Pharmaceuticals, Inc. | $378 | Travel and Lodging | In-kind items and services | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-06-06 | Boehringer Ingelheim Pharmaceuticals, Inc. | $77 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-06-06 | Boehringer Ingelheim Pharmaceuticals, Inc. | $12 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-06-05 | Novo Nordisk Inc | $1,938 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2024 | |
| 2024-05-30 | Amgen Inc. | $2,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Repatha Biological, Cardiology | 2024 | |
| 2024-05-30 | Amgen Inc. | $13 | Travel and Lodging | Cash or cash equivalent | Repatha Biological, Cardiology | 2024 | |
| 2024-05-28 | Amgen Inc. | $2,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Repatha Biological, Cardiology | 2024 | |
| 2024-05-28 | Amgen Inc. | $15 | Travel and Lodging | Cash or cash equivalent | Repatha Biological, Cardiology | 2024 | |
| 2024-05-22 | Amgen Inc. | $17 | Food and Beverage | In-kind items and services | Repatha Biological, Cardiology | 2024 | |
| 2024-05-20 | Amgen Inc. | $132 | Food and Beverage | In-kind items and services | Repatha Biological, Cardiology | 2024 | |
| 2024-05-14 | ABIOMED | $63 | Food and Beverage | In-kind items and services | Impella Device, Cardiology/Vascular Diseases | 2024 | |
| 2024-05-02 | W. L. Gore & Associates, Inc. | $36 | Food and Beverage | In-kind items and services | C3 Delivery System Device, Devices | 2024 | |
| 2024-04-26 | Novo Nordisk Inc | $12 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2024 | |
| 2024-04-25 | AstraZeneca Pharmaceuticals LP | $111 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-04-24 | Bayer Healthcare Pharmaceuticals Inc. | $26 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-renal | 2024 | |
| 2024-04-22 | Kiniksa Pharmaceuticals International, plc | $23 | Food and Beverage | In-kind items and services | Arcalyst Drug, Not Applicable | 2024 | |
| 2024-04-22 | Abbott Laboratories | $16 | Food and Beverage | In-kind items and services | AMPLATZER AMULET Device, Structural Heart | 2024 | |
| 2024-04-18 | Lilly USA, LLC | $1,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2024 | |
| 2024-04-18 | Amgen Inc. | $131 | Food and Beverage | In-kind items and services | Repatha Biological, Cardiology | 2024 | |
| 2024-04-18 | Boston Scientific Corporation | $30 | Food and Beverage | In-kind items and services | Device, General - Vascular Intervention_PI | 2024 | |
| 2024-04-15 | Amgen Inc. | $12 | Food and Beverage | In-kind items and services | Repatha Biological, Cardiology | 2024 | |
| 2024-04-03 | Shockwave Medical, Inc | $136 | Food and Beverage | In-kind items and services | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter Device, Lithoplasty | 2024 | |
| 2024-04-03 | Medtronic, Inc. | $15 | Food and Beverage | In-kind items and services | LINQ II Device, Cardiac Diagnostics and Monitoring | 2024 | |
| 2024-04-02 | Amgen Inc. | $2,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Repatha Biological, Cardiology | 2024 |
The latest 200 records of 1,387.
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Washington, MO, county Franklin County, MO, state Missouri; placed by its city name.
| Measure | Place (city or town) Washington, MO | County Franklin County, MO | State Missouri |
|---|---|---|---|
| Population B01003 | 15,130 | 105,950 | 6,191,814 |
| Population, 2020 census P1 | 14,500 | 104,682 | 6,154,913 |
| Median age B01002 | 43.1 | 41.8 | 39.0 |
| Under 18 B01001 | 20.9% | 22.4% | 22.3% |
| 65 and over B01001 | 20.1% | 19.2% | 17.9% |
| Households B11001 | 6,702 | 43,036 | 2,508,227 |
| Foreign born B05002 | 0.9% | 1.4% | 4.5% |
| Median household income B19013 | $79,173 | $73,165 | $70,702 |
| Median family income B19113 | $105,811 | $90,136 | $91,360 |
| Per capita income B19301 | $42,762 | $37,792 | $39,695 |
| Poverty rate B17001 | 7.9% | 8.2% | 12.6% |
| Unemployment rate B23025 | 3.8% | 4.3% | 4.0% |
| Civilian labor force B23025 | 8,054 | 52,951 | 3,120,639 |
| Mean commute (minutes) B08013 | 21.1 | 28.3 | 23.5 |
| Bachelor's degree or higher B15003 | 32.3% | 23.7% | 32.4% |
| Housing units B25001 | 6,889 | 46,312 | 2,825,287 |
| Owner-occupied B25003 | 74.0% | 76.5% | 68.1% |
| Renters B25003 | 26.0% | 23.5% | 31.9% |
| Median home value B25077 | $231,800 | $227,600 | $230,300 |
| Median gross rent B25064 | $827 | $893 | $1,033 |
| White, not Hispanic B03002 | 91.7% | 88.7% | 76.3% |
| Black B03002 | 0.3% | 0.9% | 10.9% |
| Hispanic or Latino B03002 | 2.1% | 2.3% | 5.2% |
| Asian B03002 | 0.2% | 0.4% | 2.1% |
| American Indian and Alaska Native B03002 | 0.2% | 0.1% | 0.2% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Washington, MO.
Comments